You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Özel Durumlarda <strong>Sigara</strong> <strong>Bırakma</strong><br />
24. ASPECT Consortium: Tobacco or health<br />
in the European Union. Belgien: European<br />
Commission 2004; 1–295.<br />
25. Doll R, Peto R, Boreham J, Sutherland I: Mortality<br />
in relation to smoking: 50 years’ observations<br />
on male British doctors. Bmj 2004; 328: 1519.<br />
26. Connett JE, Murray RP, Buist AS, et al. Changes<br />
in smoking status affect women more than men:<br />
results of the lung health study. Am J Epidemiol<br />
2003; 157: 973–979.<br />
27. Kanner RE, Connett JE, Williams DE, et al.<br />
Effects of randomized assignment to a smoking<br />
cessation inter<strong>ve</strong>ntion and changes in smoking<br />
habits on respiratory symptoms in smokers with<br />
early chronic obstructi<strong>ve</strong> pulmonary disease:<br />
the lung health study. Am J Med 1999; 106:<br />
410–416.<br />
28. Scanlon PD, Connett JE, Waller LA, et al.<br />
Smoking cessation and lung function in mildto-moderate<br />
chronic obstructi<strong>ve</strong> pulmonary<br />
disease. The lung health study. Am J Respir Crit<br />
Care Med 2000; 161: 381–390.<br />
29. Makris D, Moschandreas J, Damianaki A, et<br />
al. Exacerbations and lung function decline in<br />
COPD: new insights in current and exsmokers.<br />
Respir Med 2007; 101: 1305–1312.<br />
30. Shahab L, Jarvis MJ, Britton J,West R: Prevalence,<br />
diagnosis and relation to tobacco dependence<br />
of chronic obstructi<strong>ve</strong> pulmonary disease in a<br />
nationally representati<strong>ve</strong> population sample.<br />
Thorax 2006; 61: 1043–7.<br />
31. Andreas S, Hering T, Mühlig S, Nowak D,<br />
Raupach T, Worth H: Smoking Cessation in<br />
Chronic Obstructi<strong>ve</strong> Pulmonary Disease. Dtsch<br />
Arztebl Int 2009; 106(16): 276–82.<br />
32. Wagena EJ, Zeegers MP, van Schayck<br />
CP,Wouters EF: Benefits and risks of<br />
pharmacological smoking cessation therapies<br />
in chronic obstructi<strong>ve</strong> pulmonary disease. Drug<br />
Saf 2003; 26: 381–403.<br />
33. van der Meer RM,Wagena EJ, Ostelo RW,<br />
Jacobs JE et al.: Smoking cessation for chronic<br />
obstructi<strong>ve</strong> pulmonary disease. Cochrane<br />
Database Syst Rev 2003: CD002999.<br />
34. Wagena EJ, van der Meer RM, Ostelo RJ, Jacobs<br />
JE et al.: The efficacy of smoking cessation<br />
strategies in people with chronic obstructi<strong>ve</strong><br />
pulmonary disease: results from a systematic<br />
review. Respir Med 2004; 98: 805–15.<br />
35. Hughes J, Stead L, Lancaster T: Antidepressants<br />
for smoking cessation. Cochrane Database Syst<br />
Rev 2004: CD000031.<br />
36. Patel K, Schlundt D, Larson C, Wang H,<br />
Brown A, Hargrea<strong>ve</strong>s M: Chronic illness and<br />
smoking cessation. Nicotine Tob Res. 2009<br />
Aug;11(8):933-9.<br />
37. Reichert J, Araújo AJ, Gonçal<strong>ve</strong>s CM, Godoy<br />
I, Chatkin JM, Sales MP, Santos SR; Smoking<br />
cessation guidelines. J Bras Pneumol.<br />
2008;34(10):845-880.<br />
51